Seres Therapeutics Announces Appointment of Thomas J. DesRosier as Chief Legal Officer and Executive Vice President

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. IBM
4. META
5. MSFT
6. NAVN
7. DFTX
8. CNC
9. KFY
10. SPY

Go back to Seres Therapeutics Announces Appointment of Thomas J. DesRosier as Chief Legal Officer and Executive Vice President

Seres Therapeutics (MCRB) Misses Q1 EPS by 2c

May 16, 2016 7:12 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.50), $0.02 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $2.71 million versus the consensus estimate of $1.25 million.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

... More